Health
First patient fitted with Carmat artificial heart dies
Publish Date: Mar 04, 2014
First patient fitted with Carmat artificial heart dies
  • mail
  • img
newvision

The first patient fitted with an artificial heart made by the French company Carmat has died, the hospital that had performed the transplant in December said on Monday.

The 76-year-old man died on Sunday, 75 days after the operation, the Georges Pompidou European Hospital in Paris said in a statement, adding that the cause of his death could not be known for sure at this stage.

When he was fitted with the device, the man was suffering from terminal heart failure, when the sick heart can no longer pump enough blood to sustain the body, and was said to have only a few weeks, or even days, to live.

Carmat's bioprosthetic device is designed to replace the real heart for as much as five years, mimicking nature's work using biological materials and sensors. It aims to help the thousands of patients who die each year while awaiting a donor, and reducing the side-effects associated with transplants.

"Carmat wishes to pay tribute to the courage and the pioneering role of this patient and his family, as well as the medical team's dedication," a company spokeswoman said.

She stressed that it was premature to draw any conclusions on Carmat's artificial heart at this stage.

Three more patients in France with terminal heart failure are due to be fitted with the device. The clinical trial will be considered a success if the patients survive with the implant for at least a month.

If it passes the test, Carmat has said it would fit the device into about 20 patients with less severe heart failure. Reuters

 

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
Committee set up to clear HIV/AIDS messages
The team will scrutinize and clear all anti-HIV/AIDS campaign messages before they are disseminated to the public....
Ugandan team takes Ebola experience to Liberia
A team of Ugandan health workers are deployed by the WHO to provide medical support for an Ebola treatment centre in Liberia's capital....
New test fast-tracks diagnosis for malaria
A new invention can cheaply and accurately diagnose malaria infection in just a few minutes using only a droplet of blood....
Mwinyi impressed by cancer ward progress
Former president of Tanzania, Ali Hassan Mwinyi has commended the construction of Rotary and Centenary Bank cancer ward...
Drug resistant TB on increase in Lango region
The number of cases of Multi Drug Resistant(MDR) tuberculosis(TB) is worrying health workers...
Prototype Ebola drug clears early test hurdle
A prototype drug that has been urgently given to a handful of patients with Ebola has cleared an important test hurdle....
Do you think banning the sale of single cigarette sticks will help regulate tobacco production?
yes
No
Can't Say
follow us
subscribe to our news letter